Therapeutic drug monitoring. Practical considerations for primary care physicians
Kisor, D.F.; Mehta, V.; Vieira-Fattahi, S.; Sterchele, J.A.
Postgraduate Medicine 87(4): 239-41 244-6
1990
ISSN/ISBN: 0032-5481 PMID: 2315248 Document Number: 353916
Primary care physicians who understand the complexities of drug dosing may be able to provide their patients with more effective pharmacologic therapy. Standard or empirical methods of dosing are appropriate for most agents. The evolution of pharmacokinetics and clinically useful drug assays has led to pharmacokinetic dosing, a more sophisticated and exact method of dosing certain agents.
Document emailed within 1 workday
Related Documents
Michel, Y.; Brandstatter, H.; Gaspoz, J-M.; Muggli, F.; Pechère-Bertschi, A. 2009: Interpretation of 24h ambulatory blood pressure monitoring by primary care physicians Revue Medicale Suisse 5(218): 1876-1880Miller, R.; Nowosiad, D.; Warnes, D.M.; De Wet, J.M. 1982: The role of therapeutic drug monitoring in the care of epileptic patients South African Medical Journal 62(15): 512-515
Frewin, D.B.; Shaw, D.R.; Bochner, F. 1982: Therapeutic drug monitoring: a survey of sub- and supra-therapeutic serum drug levels in a large teaching hospital New Zealand Medical Journal 95(719): 774-776
Kulik, T.B.; Kobyłecka, E.; Modzelewska, T.; Kachaniuk, H.; Stefanowicz, A. 2003: Primary health care physicians' knowledge of prophylactics of drug abuse Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 58(2): 220-226
Ratanajamit, C.; Kaewpibal, P.; Setthawacharavanich, S.; Faroongsarng, D. 2009: Effect of pharmacist participation in the health care team on therapeutic drug monitoring utilization for antiepileptic drugs Journal of the Medical Association of Thailand 92(11): 1500-1507
Jünger, C.; Rathmann, W.; Giani, G. 1999: Drug prescribing in primary health care for diabetic and non-diabetic patients: effect of therapeutic drug budgeting Gesundheitswesen 61(12): 607-613
Kruse, W.; Rampmaier, J.; Ullrich, G.; Weber, E. 1994: Patterns of drug compliance with medications to be taken once and twice daily assessed by continuous electronic monitoring in primary care International Journal of Clinical Pharmacology and Therapeutics 32(9): 452-457
Muñoz, O.; Guiscafré, H.; Bronfman, M.; Gutiérrez, G. 1988: Strategies for improving the therapeutic patterns used in acute diarrhea in primary medical care units. IV. Features of the treatments prescribed by the family physicians and the patients Archivos de Investigacion Medica 19(4): 371-384
Jani, I.V.; Sitoe, N.ád.E.; Chongo, P.L.; Alfai, E.R.; Quevedo, J.I.; Tobaiwa, O.; Lehe, J.D.; Peter, T.F. 2011: Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testing Aids 25(6): 807-812
Begaud, B.; Haramburu, F.; Père, J.C.; Dangoumau, J. 1982: Practical considerations in attributing drug effects: 1 000 cases Therapie 37(4): 415-420
Lerescu, L.; Tucureanu, C.ăt.ăl.; Caraş, I.; Neagu, S.; Melinceanu, L.; Sălăgeanu, A. 2008: Primary cell culture of human adenocarcinomas--practical considerations Roumanian Archives of Microbiology and Immunology 67(3-4): 55-66
Borcherding, S.M.; Stevens, R.; Nicholas, R.A.; Corley, C.R.; Self, T. 1996: Quinolones: a practical review of clinical uses, dosing considerations, and drug interactions Journal of Family Practice 42(1): 69-78
Martini, P.F.; Segoloni, G.P.; Jeantet, A.; Giachino, G.; Mangiarotti, G.; Nebiolo, P.E.; Longo, L.; Piancino, G. 1980: Diabetic nephropathy. Review of the current status and practical considerations concerning etiopathogenetic, clinical and therapeutic aspects Minerva Medica 71(38): 2709-2723
Rodríguez Moreno, C.; Campoamor Landín, F.; Zaforteza Dezcallar, M.; Verdejo González, A.; Muro Pascual, V.; Martín Martín, M.V. 1998: Antibiotics policy in primary care. Practical experience in a health district. Primary Care Antibiotics Commission of the Mallorca Area Atencion Primaria 21(5): 315-320
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Shaw, L.M.; Brayman, K.L. 1994: FK-506 therapeutic drug monitoring Clinical Chemistry 40(12): 2207-2208
Mo, P.S. 1983: Therapeutic drug monitoring Zhonghua Nei Ke Za Zhi 22(3): 176-180
Gram, L.F. 1995: Attitude and considerations of Danish physicians towards reporting of adverse drug reactions--a questionnaire study under European direction Ugeskrift for Laeger 157(12): 1692-1694
Patrick, C.H. 1995: Therapeutic drug monitoring in neonates Neonatal Network: Nn 14(2): 21-26
Radziwoń-Zaleska, M.; Matsumoto, H.; Skalski, M.; Androsiuk, W.; Dziklińska, A.; Kunicki, P.K. 2000: Therapeutic drug monitoring in depression Polish Journal of Pharmacology 52(4): 255-266